Source: Medicines Authority (MT) Revision Year: 2017 Publisher: Dompé farmaceutici S.p.A., Via San Martino, 12, 20122 Milano, Italy
Fluifort 90 mg/ml syrup.
| Pharmaceutical Form |
|---|
|
Syrup. |
100 ml syrup contain:
active ingredient: carbocysteine lysine salt monohydrate equivalent to 9 g carbocysteine lysine salt
Excipients: Saccharose, methyl-p-hydroxybenzoate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Carbocisteine |
Carbocisteine (5-carboxymethyl L-cysteine) has been shown in normal and bronchitic animal models to affect the nature and amount of mucus glycoprotein that is secreted by the respiratory tract. An increase in the acid:neutral glycoprotein ratio of the mucus and a transformation of serous cells to mucus cells is known to be the initial response to irritation and will normally be followed by hypersecretion. |
| List of Excipients |
|---|
|
Saccharose |
Amber glass bottle sealed with aluminium cap and graduated cup in neutral PP. 200 ml bottle.
Dompé farmaceutici S.p.A., Via San Martino, 12, 20122 Milano, Italy
MA118/00201
3rd January, 2007 / 1st October 2013
| Drug | Countries | |
|---|---|---|
| FLUIFORT | Hong Kong, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
